Aurobindo Pharma Ltd’s consolidated net profit increased manifold at Rs 501 crore in the fourth quarter ended March 31, 2014 compared to Rs 108 crore in the year-ago period driven by growth in formulations sale.
The total revenue of the Hyderabad-based company grew by 48.4 per cent at Rs 2,329 crore (Rs 1,570 cr).
For the full-year, profit increased to Rs 1,173 crore (Rs 294 cr). Total revenue grew to Rs 8,100 crore (Rs 5,855 crore).